Table 1

The correlation of microRNA-451 expression level with different clinical and pathological parameters in patients with colorectal carcinoma

ParametersTotal no.High expressionLow expressionNormal expressionp Value
Age
 ≤6014 (20.0%)2 (14.3%)11 (78.6%)1 (7.1%)0.507
 >6056 (80.0%)3 (5.4%)48 (85.7%)5 (8.9%)
Gender
 Male35 (50.0%)1 (2.9%)32 (91.4%)2 (5.7%)0.236
 Female35 (50.0%)4 (11.4%)27 (77.1%)4 (11.4%)
Size
 ≤40 mm39 (55.7%)2 (5.1%)33 (84.6%)4 (10.3%)0.673
 >40 mm31 (44.3%)3 (9.7%)26 (83.9%)2 (6.5%)
Location
 Colon54 (77.1%)5 (9.3%)45 (83.3%)4 (7.4%)0.391
 Rectum16 (22.9%)0 (0.0%)14 (87.5%)2 (12.5%)
Grade
 I9 (12.9%)0 (0.0%)9 (100.0%)0 (0.0%)0.340
 II52 (74.3%)5 (9.6%)41 (78.8%)6 (11.5%)
 III9 (12.9%)0 (0.0%)9 (100.0%)0 (0.0%)
Stage
 I/II41 (58.6%)4 (9.8%)35 (85.4%)2 (4.9%)0.282
 III/IV29 (41.4%)1 (3.4%)24 (82.8%)4 (13.8%)
Associated adenoma
 Yes35 (50.0%)0 (0.0%)32 (91.4%)3 (8.6%)0.025
 No35 (50.0%)5 (14.3%)27 (77.1%)3 (8.6%)
Lymphovascular permeation
 Yes15 (21.4%)0 (0.0%)14 (93.3%)1 (6.7%)0.443
 No55 (78.6%)5 (9.1%)45 (81.8%)5 (9.1%)
Perineural infiltration
 Yes6 (8.6%)1 (16.7%)4 (66.7%)1 (16.7%)0.455
 No64 (91.4%)4 (6.3%)55 (85.9%)5 (7.8%)
Microsatellite instability status
 Yes12 (17.1%)2 (16.7%)9 (75.0%)1 (8.3%)0.370
 No58 (82.9%)3 (5.2%)50 (86.2%)5 (8.6%)
Hereditary non-polyposis colorectal cancer
 Presence6 (8.6%)0 (0.0%)6 (100.0%)0 (0.0%)0.542
 Not detected64 (91.4%)5 (7.8%)53 (82.8%6 (9.4%)
Cancer recurrence
 Yes20 (28.6%)0 (0.0%)16 (80.0%)4 (20.0%)0.028
 No50 (71.4%)5 (10.0%)43 (86.0%)2 (4.0%)
  • Bold is p value<0.05.